Search Results

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on April 1, 2020, to shareholders of record as of February 28, 2020. The indicated annual dividend rate is $0.88 per share of common stock. 

Baxter Completes Acquisition of Seprafilm Adhesion Barrier

Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million.

Baxter and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device

Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry (IC) technology. IC is considered the "gold standard"1  to accurately measure a patient’s calorie needs, or resting energy expenditure (REE).

Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada

Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Spectral Medical Inc. (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis.

Baxter Aids Relief Efforts in Australia Bushfire and Puerto Rico Earthquake Disasters

2020 has brought devastation to Australia and Puerto Rico. The Baxter team is responding in real-time.

Embracing Differences Drives Results

Baxter recognized for its commitment to diversity

Baxter to Present at the 9th Annual SVB Leerink Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y. on Wednesday, February 26, 2020. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time.

Baxter Supporting Puerto Rico Recovery, Product Supply Continuity

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today issued this statement: Over the last several days, the people of Puerto Rico have experienced multiple earthquakes and aftershock effects, disrupting the power supply, displacing residents and complicating basic needs. Our hearts are with the people of Puerto Rico, and we are grateful that our employees are all safe and accounted for.

Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.

In Memoriam: Bob Parkinson

Robert L. Parkinson, Jr., who served as Chairman and CEO of Baxter International from 2004 through 2015, passed away on December 19.